Akiko Sumitomo

593 total citations
16 papers, 397 citations indexed

About

Akiko Sumitomo is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Akiko Sumitomo has authored 16 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Akiko Sumitomo's work include Cannabis and Cannabinoid Research (4 papers), Autophagy in Disease and Therapy (4 papers) and Tryptophan and brain disorders (4 papers). Akiko Sumitomo is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), Autophagy in Disease and Therapy (4 papers) and Tryptophan and brain disorders (4 papers). Akiko Sumitomo collaborates with scholars based in United States, Japan and Canada. Akiko Sumitomo's co-authors include Toshifumi Tomoda, Akira Sawa, Hanna Jaaro-Peled, Etienne Sibille, Takeshi Sakurai, Minae Niwa, Rammohan Shukla, Dwight F. Newton, Robert G. Roeder and Habil Zare and has published in prestigious journals such as Molecular and Cellular Biology, Neuroscience and Human Molecular Genetics.

In The Last Decade

Akiko Sumitomo

16 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akiko Sumitomo United States 11 211 105 60 51 47 16 397
Talia A. Atkin United States 8 348 1.6× 167 1.6× 60 1.0× 31 0.6× 30 0.6× 8 481
Xuebo Yan China 12 228 1.1× 133 1.3× 40 0.7× 83 1.6× 18 0.4× 28 557
Ammar Kutiyanawalla United States 12 221 1.0× 166 1.6× 26 0.4× 25 0.5× 39 0.8× 13 570
Richard C. Rice United States 13 314 1.5× 174 1.7× 47 0.8× 30 0.6× 40 0.9× 20 619
David Chun Cheong Tsui United States 7 290 1.4× 104 1.0× 76 1.3× 26 0.5× 43 0.9× 14 579
Paul Halley United States 9 224 1.1× 75 0.7× 35 0.6× 22 0.4× 21 0.4× 10 423
HJ Kim South Korea 3 169 0.8× 55 0.5× 67 1.1× 105 2.1× 77 1.6× 6 467
Natália Assaife‐Lopes Portugal 9 171 0.8× 203 1.9× 30 0.5× 15 0.3× 29 0.6× 11 460
Yi Jayne Tan Singapore 15 150 0.7× 165 1.6× 51 0.8× 24 0.5× 60 1.3× 43 536
Ji-Seon Seo South Korea 8 158 0.7× 96 0.9× 60 1.0× 9 0.2× 54 1.1× 9 377

Countries citing papers authored by Akiko Sumitomo

Since Specialization
Citations

This map shows the geographic impact of Akiko Sumitomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Sumitomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Sumitomo more than expected).

Fields of papers citing papers by Akiko Sumitomo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Sumitomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Sumitomo. The network helps show where Akiko Sumitomo may publish in the future.

Co-authorship network of co-authors of Akiko Sumitomo

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Sumitomo. A scholar is included among the top collaborators of Akiko Sumitomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Sumitomo. Akiko Sumitomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tomoda, Toshifumi, Akiko Sumitomo, Dwight F. Newton, & Etienne Sibille. (2022). Molecular origin of somatostatin-positive neuron vulnerability. Molecular Psychiatry. 27(4). 2304–2314. 10 indexed citations
2.
Tomoda, Toshifumi, Akiko Sumitomo, Rammohan Shukla, et al.. (2021). BDNF controls GABAAR trafficking and related cognitive processes via autophagic regulation of p62. Neuropsychopharmacology. 47(2). 553–563. 25 indexed citations
3.
Shukla, Rammohan, Dwight F. Newton, Akiko Sumitomo, et al.. (2021). Molecular characterization of depression trait and state. Molecular Psychiatry. 27(2). 1083–1094. 28 indexed citations
4.
Sumitomo, Akiko & Toshifumi Tomoda. (2021). Autophagy in neuronal physiology and disease. Current Opinion in Pharmacology. 60. 133–140. 10 indexed citations
5.
Prévot, Thomas D., Akiko Sumitomo, Toshifumi Tomoda, et al.. (2020). Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation. Cerebral Cortex. 31(2). 1395–1408. 23 indexed citations
6.
Takayanagi, Yoichiro, Koko Ishizuka, Thomas Munk Laursen, et al.. (2020). From population to neuron: exploring common mediators for metabolic problems and mental illnesses. Molecular Psychiatry. 26(8). 3931–3942. 12 indexed citations
7.
Sumitomo, Akiko, Dean Thumkeo, Kentaro Ito, et al.. (2018). LPA Induces Keratinocyte Differentiation and Promotes Skin Barrier Function through the LPAR1/LPAR5-RHO-ROCK-SRF Axis. Journal of Investigative Dermatology. 139(5). 1010–1022. 35 indexed citations
8.
Ooms, Maarten, Tetsuya Tsujikawa, Talakad G. Lohith, et al.. (2018). [11C](R)-Rolipram positron emission tomography detects DISC1 inhibition of phosphodiesterase type 4 in live Disc1 locus-impaired mice. Journal of Cerebral Blood Flow & Metabolism. 39(7). 1306–1313. 1 indexed citations
9.
Sumitomo, Akiko, Hiroshi Yukitake, Eiji Warabi, et al.. (2018). Ulk2 controls cortical excitatory–inhibitory balance via autophagic regulation of p62 and GABAA receptor trafficking in pyramidal neurons. Human Molecular Genetics. 27(18). 3165–3176. 37 indexed citations
10.
Sumitomo, Akiko, Nancy J. Butcher, Erik Boot, et al.. (2018). A mouse model of 22q11.2 deletions: Molecular and behavioral signatures of Parkinson’s disease and schizophrenia. Science Advances. 4(8). eaar6637–eaar6637. 34 indexed citations
11.
Sumitomo, Akiko, Nao J. Gamo, Takatoshi Hikida, et al.. (2017). Methylphenidate and Guanfacine Ameliorate ADHD-Like Phenotypes in <b><i>Fez1</i></b>-Deficient Mice. PubMed. 3(4). 223–233. 10 indexed citations
12.
Sumitomo, Akiko, et al.. (2016). Ulk1 protects against ethanol-induced neuronal stress and cognition-related behavioral deficits. Neuroscience Research. 117. 54–61. 6 indexed citations
13.
Niwa, Minae, Atsushi Saito, Kazuhiro Ishii, et al.. (2016). DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1. Molecular Psychiatry. 21(11). 1488–1489. 55 indexed citations
14.
Tomoda, Toshifumi, Akiko Sumitomo, Hanna Jaaro-Peled, & Akira Sawa. (2016). Utility and validity of DISC1 mouse models in biological psychiatry. Neuroscience. 321. 99–107. 56 indexed citations
15.
Sumitomo, Akiko, Keiji Matsui, Kana Inoue, et al.. (2012). Mediator Subunits MED1 and MED24 Cooperatively Contribute to Pubertal Mammary Gland Development and Growth of Breast Carcinoma Cells. Molecular and Cellular Biology. 32(8). 1483–1495. 35 indexed citations
16.
Sumitomo, Akiko, Kana Inoue, Hiroshi Matsuoka, et al.. (2010). The Transcriptional Mediator Subunit MED1/TRAP220 in Stromal Cells Is Involved in Hematopoietic Stem/Progenitor Cell Support through Osteopontin Expression. Molecular and Cellular Biology. 30(20). 4818–4827. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026